Comparison of the in vitro Anti-Inflammatory Effect of Cannabidiol to Dexamethasone
Yiming Wang,Xue Wang,Yang Yang,Qianghua Quan,Tong Huo,Simin Yang,Ruijun Ju,Quan An
DOI: https://doi.org/10.2147/CCID.S378798
2022-09-17
Abstract:Yiming Wang, 1– 3 Xue Wang, 1– 3 Yang Yang, 1– 3 Qianghua Quan, 1– 3 Tong Huo, 1– 3 Simin Yang, 4 Ruijun Ju, 4 Quan An 1– 3, 5 1 Research and Development Department, Yunnan Baiyao Group Health Products Co, Ltd, Kunming, People's Republic of China; 2 East Asia Skin Health Research Center, Beijing, People's Republic of China; 3 Research and Development Department, REAL DermaSci & Biotech Co, Ltd, Beijing, People's Republic of China; 4 Beijing Key Laboratory of Enze Biomass Fine Chemicals, Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, People's Republic of China; 5 Research and Development Department, Yunnan Baiyao Group Shanghai Science & Technology Co, Ltd, Shanghai, People's Republic of China Correspondence: Quan An, Yunnan Baiyao Group Health Products Co, Ltd, 3686 Yunnan Baiyao Street Chenggong District, Kunming, 650500, People's Republic of China, Tel +86-13529091004, Email Background: Cannabidiol (CBD) is a non-psychoactive phytocannabinoid constituent of Cannabis sativa with pain-relieving and anti-inflammatory properties. With the emphasis on natural ingredients in cosmetics, CBD has become a new cosmetic ingredient due to its ability to alleviate inflammation. However, in-depth studies that directly compare the effective mechanism and the therapeutic potential of CBD are still needed. Purpose: The aim of the present study was to investigate the anti-inflammatory effect of CBD in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and compare it to dexamethasone (DEX). Methods: RAW264.7 macrophages in the logarithmic growth phase were incubated in the presence or absence of LPS. After that, the production of nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) were measured. A luciferase reporter assay for nuclear factor kappa B (NF-κB) was performed, and the phosphorylation levels of the mitogen-activated protein kinase (MAPK) and NF-κB signaling pathways were measured. Results: The present study indicated that CBD had a similar anti-inflammatory effect to DEX by attenuating the LPS-induced production of NO, IL-6, and TNF-α. However, only CBD attenuated JNK phosphorylation levels, and only DEX attenuated IKK phosphorylation levels. Conclusion: These results suggested that CBD and DEX exhibit similar anti-inflammatory effects on LPS-induced RAW264.7 macrophages mainly through suppressing the MAPK and NF-κB signaling pathways, but with different intracellular mechanisms. These findings suggested that CBD may be considered a natural anti-inflammatory agent for protecting skin from immune disorders. Graphical Keywords: cannabidiol, dexamethasone, LPS, RAW264.7, anti-inflammation Graphical Inflammation is a sign of the immune system response to invading pathogens. 1 The inflammatory response is connected and highly involved in various diseases such as psoriasis, atopic dermatitis, pancreatitis, and rheumatoid arthritis. 2–4 Macrophages, as the main pro-inflammatory cells, play a central role in protection from external intruders. Lipopolysaccharide (LPS) is an outer membrane component of Gram-negative bacteria that induces the release of proinflammatory cytokines. 5,6 Several studies have reported that LPS-induced macrophages activate a complex signaling network through toll-like receptor (TLR) including nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathway. 7 Moreover, the activated macrophages secrete various pro-inflammatory cytokines, such as nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). 8,9 Dexamethasone (DEX) is a well-documented immuno-suppressant drugs have benefits patients with inflammation, dermatitis, and allergies. 10–12 As a potent glucocorticoid, DEX is well tolerated with most conditions, but it has several adverse effects including weight gain, vomiting, and indigestion. 12 In recent years, there has been increasing attention focused on the anti-inflammatory effect of natural compounds due to their minimal side effects. 13–15 Cannabidiol (CBD) as the second most prevalent activate component in cannabis, has anti-inflammatory properties in treating various types of inflammation diseases, including airway inflammation, arthritis, intestinal inflammation, and skin inflammation. 16–19 The dysregulation of the endocannabinoid system (ECS) in human skin is related to various skin disorders including atopic dermatitis, acne, and hyperpigmentation. 20</su -Abstract Truncated-
dermatology